GETINGE AB/ADR (OTCMKTS:GNGBY)’s stock price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $16.22 and last traded at $16.22, with a volume of 301 shares trading hands. The stock had previously closed at $13.84.
Separately, ValuEngine lowered GETINGE AB/ADR from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd.
The firm has a market capitalization of $4.36 billion, a P/E ratio of 20.00 and a beta of 1.82. The firm has a 50 day moving average price of $14.06 and a 200-day moving average price of $14.09. The company has a current ratio of 0.87, a quick ratio of 0.55 and a debt-to-equity ratio of 0.05.
GETINGE AB/ADR Company Profile (OTCMKTS:GNGBY)
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services.
Further Reading: How is Preferred Stock Different from Common Stock?
Receive News & Ratings for GETINGE AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GETINGE AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.